China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...
The Administration for a Healthy America is RFK Jr.'s plan to tackle chronic disease, addiction and other persistent problems ...
Aging-focused biotech companies share how they're advancing therapies to slow disease, extend lifespan, and transform medicine.
The United States’ escalation of the Venezuela conflict is more than distant geopolitics. Its effects will be felt across ...
Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
The Brighterside of News on MSN
Scientists map a road to fairer, more inclusive drug development
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback